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In their recent commentary, Wallach et al. explain that
breaches of research integrity will typically do damage to
the reliability and validity of biomedical research [1]. This
may harm regulatory and clinical decision-making. Conse-
quently health care and public health may suffer. They
point out that prevalent questionable research practices like
poor study design, low power and selective reporting prob-
ably do substantially more damage than the rare occurrence
of the classical ‘‘deadly sins’’ of fabrication, falsification,
and plagiarism. Wallach et al. do not dwell much on the
causes of the shortcomings listed in their table 1 and take
the view that the remedy should come from better guide-
lines, more transparency, and mandatory training [1].
While I agree with all this, I would like to strengthen the
argumentation by first analyzing the replicability crisis and
the need for more transparency a bit further. Second, I shall
explore what biomedical research can learn about fostering
responsible research practices from other disciplines, social
sciences first and foremost. Finally, the putative determi-
nants of research misconduct and questionable research
practices will be discussed, and the actions different stake-
holders can take shall be explored.2. Replicability crisis
A 2012 Nature publication showed the reproducibility of
oncological animal studies to be embarrassingly low [2].DOI of original article: 10.1016/j.jclinepi.2017.08.021.
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tween 10% and 40% are reported [3]. This is no surprise
for methodologists, as some of the background was already
pointed out in the classical article ‘‘Why most research
findings are false’’ [4]. Next to low power and flawed study
design, especially, selective reporting of positive results
may be the most important driver of the replicability crisis.
We do not yet have a clear view on what we exactly mean
when we say that a study is replicated [5]. We also do not
know how common the problem is and what would be the
most effective ways to deal with it. A common prejudice
seems to be that replication is a second rate activity for inves-
tigators not bright enough to do innovative work. But that
might not be true given the abundance of good quality appli-
cations for the research program on replication studies of the
Netherlands Organisation for Scientific Research [6]. Inter-
estingly, the field of clinical trials may be an exception in
the sense that large prospectively registered well-designed
multicentre trials may be quite reproducible. In this arena,
even redundant replication may be an issue as can be illus-
trated in cumulative meta-analyses [7].
Wallach et al. point correctly out that there is still sub-
stantial room for improving the reliability and validity of
clinical trials as the fundament of regulatory and clinical
decision-making [1]. My point is that the situation is prob-
ably much worse in observational etiologic, diagnostic, and
prognostic research. And also that these fields can learn a
lot from the decades of experience in making randomized
clinical trials more reliable and more valid.3. Need for more transparency
Although the compliance should be improved further,
prospective trial registration is the example that can most
likely help other fields to fight selective reporting and to
improve replicability. In its full version, the idea is that
complete study protocols need to be deposited before the
start of data collection [8,9]. Later changes are possible,
but will leave traces and might be considered data-driven.
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statistical analyses start. And after the study, the archive
needs to be completed by adding the log of data collection,
the syntaxes of the analyses, the full data set and its code
book, and all results. It is debatable if and when the ele-
ments of this archive must be publicly accessible. And if
not under which conditions and to whom access will be
granted. To be able to practice transparency, a number of
conditions have to be met, such as having the essential
skills and facilities, and the means to adequately protect
the identity of study participants. And there may be nega-
tive side effects of making data public, like mala fide
misuse of data sets. For a fuller discussion, I refer to the
ten commentaries on transparency that appeared in the
February 2016 issue of this journal [10].
We should realize that the practice of transparency in the
sense outlined previously concerns the tradition of hypoth-
esis testing research. The essence of exploratory research is
that the next steps in the project are data-driven; therefore,
having a fixed study protocol is not useful. In exploratory
research ‘‘anything goes’’, as long as it is clearly reported
what has been done, and no conclusions are drawn on the
emerging ( post hoc) hypotheses.
Please note that the need to be transparent and to fight
the lack of replicability and selective reporting are also
the core elements in the Lancet REWARD Campaign that
has many university medical centers and biomedical fund-
ing agencies as signatories [11]. The core idea is simple and
started by an analysis that argued that 85% of clinical
research may be wasted [12]. The reasons for that being
avoidable were because the studies at issue have (1) irrele-
vant research questions, (2) poor research methods, (3) se-
lective reporting, or (4) poor reporting quality. The last
point links to the many (N 5 376) useful reporting guide-
lines that are currently available for biomedical research
and conveniently made accessible by the Enhancing the
QUAlity and Transparency Of health Research (Equator)
Network [13].4. What can be learned from the neighbors?
Although biomedical research is important and may
concern about half of the research volume worldwide, there
exist other academic disciplines and their experiences with
research misconduct, questionable research practices, and
replication problems might be different. Biomedical
research can learn from that and might consider adoption
of effective solutions developed by its disciplinary neigh-
bors. Although the evidence is thin, it seems that qualitative
empirical research and hermeneutic and reflective ap-
proaches that are prevalent in the Humanities and in Law
schools suffer from partly other threats to reliability and
validity. Plagiarism, selective use of sources, and lack of
transparency in the various steps of the argumentation
seems to be relatively important in these domains. And inthe natural sciences, replicability may be less a problem
than elsewhere due to its tradition of internal replication,
intense international collaboration, publishing preprints,
and making available data sets to interested colleagues.
For a comprehensive orientation, I recommend the recent
report on Fostering Integrity of Research by the US
National Academies of Science [14] and the European
Commission briefing article on Research Integrity: What
it Means, Why it Is Important, and How we Might Protect
it [15].
A lot of inspiring work has been done in the Social Sci-
ences. In a way it started with the case of data fabrication
by Diederik Stapel that deeply shocked both the general
public and scientists. An excellent investigation report ap-
peared [16], and Tilburg University and the social sci-
ences at large responded with important improvements
and preventive measures. Recently, Klaas Sijtsma, who
succeeded Stapel as dean of the School of Social and
Behavioral Sciences at Tilburg University, presented a
keynote lecture on the 5th World Conference on Research
Integrity (WCRI) with the telling title ‘‘Never waste a
good crisis’’ [17].
Another game changer in social science was the 2015
Science publication on ‘‘Estimating the reproducibility of
psychological science’’ [18]. That made clear that on repli-
cation, the effect size of 100 ‘‘cornerstone publications’’
were only half of the initial magnitude, and the proportion
of significant studies deceased from 97% to 36%. This lead
to intensive soul searching and gave substantial momentum
to the Center of Open Science [19] that introduced a num-
ber of highly relevant improvements like the Open Science
Framework [20], the Transparency and Openness Promo-
tion guidelines [21,22], and Registered Reports [23,24].
Recently, the ‘‘Manifesto for Reproducible Science’’ was
published, highlighting the practical measures that most
likely would help in solving the issues [25]. These develop-
ments could inspire further improvements in biomedical
research. Also, the concept of ‘‘researcher degrees of
freedom’’ and the need to restrict these as much as possible
seems very relevant for biomedical research [26].5. Determinants of research misbehavior
Ideally, interventions to prevent, diagnose, or treat the
various forms of research misbehavior should be based on
evidence on its most important determinants. Unfortu-
nately, so far the evidence is scarce, and the field of
‘‘meta-research’’ is still in its infancy. The good news is
that this seems to change fast, with increasing funds for
research (e.g., in the European Union Horizon 2020 pro-
gram [27] and programs on Fostering Responsible Research
Practices [28] and Replication Studies [6] in the
Netherlands). Also, research institutes are emerging,
similar to the Collaboration for Research Integrity and
Transparency [29], were Wallach et al. are based, the
145L.M. Bouter / Journal of Clinical Epidemiology 96 (2018) 143e146Meta-Research Innovation Center at Stanford [30], and the
Meta-Research Center at Tilburg University [31].
Having said that, we do have some insights in what the
most likely root causes of the various research misbehav-
iors actually are [14,15]. The big picture seems to be that
scientists experience dilemmas and conflicts of interest in
daily practice that arise from the fact that what is good
for the validity and reliability of science is not always good
for their personal career. Many rewards are linked to having
positive and spectacular results as these are published more
easily in high impact journals and will be cited more often.
The various forms of research misbehavior have in com-
mon that they can help to get positive and spectacular re-
sults. Thus, the current reward criteria in science act
partly as perverse incentive. It also seems likely that deter-
minants of research misbehavior are manifold and can
concern the individual researcher, the research climate in
with he or she works, and the system of science at large.
At the level of the science system, perceived organiza-
tional injustice due to almost exclusively rewarding posi-
tive and spectacular results seems to play an important
role, as is the perceived (low) likelihood of being caught
by reviewers or colleagues. Important determinants con-
nected to the research climate may be perceived norm
adherence, level of competition and level of social support
in the group, and the quality and intensity of mentoring and
supervision. At the level of the individual scientist, impor-
tant determinants of research misbehavior may be the de-
pendency on external funding, perceived work pressure,
and personal norm subscription. Unfortunately, the evi-
dence on most of these determinants is weak, and they have
never been studied simultaneously.6. There is no magic bullet
Taking all this together, it seems reasonable to conclude
that (1) there are serious problems we need to fix in science,
(2) multiple stakeholders have a role to play, (3) the
evidence-base for this needs further strengthening, and (4)
we should exchange experiences and learn from each other
[32,33]. Although individual scientists are responsible for
their own behavior and any minor or major breaches of
research integrity they commit, we need to recognize that
research institutions, funding agencies, and scientific jour-
nals can and should take measures to foster responsible
research practices and to detect and handle instances of ma-
jor or minor research misbehaviors.
Research institutions have the duty to have clear codes and
procedures regarding research integrity, and to ensure good
facilities, adequate mentoring, and training in responsible
conduct of research at all levels [34]. Specific arrangements
must bemade to enable transparency and tomonitor research
quality, such as good data management and storage facilities,
adequate methodological and statistical support, and a sys-
tem of internal audits. Institutions should tackle the perverseincentives in their reward systems and promote a research
climate in which dilemmas can be openly discussed, and
learning from mistakes is encouraged. Institutions may
decide to explore the salient aspects of their research climate
and identify promising ways to promote responsible conduct
of research by consulting their community of researchers. An
example is the ongoing project Academic Research Climate
in Amsterdam that involves two universities and two univer-
sity medical centers [35].
Funding agencies should demand that research institu-
tions fulfill their duties of care in the sense outlined previ-
ously. They should also make transparency ‘‘from protocol
to publication’’ obligatory and be clear about the required
level of open access and open data. All research proposals
should convincingly argue that the research question is rele-
vant and not yet sufficiently studied. Funding agencies need
to strike an adequate balance between innovation and repli-
cation in their portfolio and also offer grants for meta-
research. With a clever mix of ‘‘sticks and carrots’’ funding
agencies can have a profound impact on the behavior of re-
searchers and their institutions [36].
Scientific journals have a key role in preventing selective
publication and in promoting reporting quality. They should
consider adoption of Registered Reports as this is an effec-
tive way to focus solely on the relevance of the research
question and the soundness of the methods, and to avoid be-
ing distracted by the results of the study [23,24]. This is
done by first submitting the introduction and methods sec-
tions and starting data collection only when the article is
accepted for publication on the condition that the study is
performed as planned and adequately reported. Scientific
journals should adopt as much as possible the Transparency
and Openness Promotion guidelines [21,22] and enable and
encourage postpublication peer review.
Research integrity is an important issue for all disciplinary
domains, for all regions and countries in the world, and for
multiple stakeholders. The scarcity of good quality evidence
and the rapid rate at which the field is evolvingmake it neces-
sary to exchange experiences, to identify best practices, to
collaborate, and to align interventions. For this, both national
and international platforms are emerging. An example of a
national platform is the Netherlands Research Integrity
Network [37]. NetherlandsResearch IntegrityNetwork orga-
nizes symposia on responsible conduct of research education
and on meta-research, convenes closed meetings for confi-
dential counselors and committee members involved in
handling allegations of breaches of research integrity, and
maintains a website that offers a wealth of information on
these topics.
An example of an international platform is the series of
World Conferences of Research Integrity the fifth of which
was held inAmsterdam in 2017 [38]. After the event, the con-
ferencewebsitewas enrichedwith PDFs of almost all presen-
tations and videos of the keynote lectures. The 2nd WCRI
yielded the Singapore Statement that is taken as anchor by
many national and international codes of conduct [39]. The
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need to register meta-research and to evaluate the efficacy of
all measures and interventions aimed at fostering research
integrity [40]. The idea is that the research integrity commu-
nity should practice what it preaches and make a strong plea
for evidence-based policies.
To return to the jargon of clinical research, there is no
magic bullet. We need a mix of different interventions to
prevent breaches of research integrity, detect and handle
cases of misbehavior, and to foster responsible research
practices. Interdisciplinary and international collaboration
and exchange of best practices, that includes all relevant
stakeholders, should form the basis of rapid progress.
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